Erste Asset Management’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-34,000	Closed	-$251K	–	687
2024 Q4	$251K	Hold	34,000	–	–	﹤0.01%	478
2024 Q3	$327K	Hold	34,000	–	–	﹤0.01%	465
2024 Q2	$272K	Hold	34,000	–	–	﹤0.01%	456
2024 Q1	$479K	Hold	34,000	–	–	0.01%	426
2023 Q4	$292K	Hold	34,000	–	–	﹤0.01%	464
2023 Q3	$155K	Hold	34,000	–	–	﹤0.01%	491
2023 Q2	$240K	Hold	34,000	–	–	﹤0.01%	477
2023 Q1	$209K	Hold	34,000	–	–	﹤0.01%	485
2022 Q4	$213K	Hold	34,000	–	–	﹤0.01%	490
2022 Q3	$324K	Hold	34,000	–	–	0.01%	468
2022 Q2	$370K	Hold	34,000	–	–	0.01%	458
2022 Q1	$568K	Sell	34,000 -30,000	-47%	-$501K	0.01%	423
2021 Q4	$1.24M	Hold	64,000	–	–	0.02%	341
2021 Q3	$1.52M	Hold	64,000	–	–	0.03%	298
2021 Q2	$1.69M	Hold	64,000	–	–	0.03%	304
2021 Q1	$1.9M	Hold	64,000	–	–	0.05%	275
2020 Q4	$3.05M	Buy	64,000 +21,000	+49%	+$1,000K	0.08%	220
2020 Q3	$1.39M	Hold	43,000	–	–	0.05%	282
2020 Q2	$1.17M	Hold	43,000	–	–	0.05%	282
2020 Q1	$1.29M	Hold	43,000	–	–	0.07%	231
2019 Q4	$1.2M	Hold	43,000	–	–	0.05%	264
2019 Q3	$774K	Buy	+43,000	New	+$774K	0.04%	285